JP2006507807A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006507807A5 JP2006507807A5 JP2004524480A JP2004524480A JP2006507807A5 JP 2006507807 A5 JP2006507807 A5 JP 2006507807A5 JP 2004524480 A JP2004524480 A JP 2004524480A JP 2004524480 A JP2004524480 A JP 2004524480A JP 2006507807 A5 JP2006507807 A5 JP 2006507807A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- gene
- sequence number
- composition
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims 82
- 239000000203 mixture Substances 0.000 claims 35
- 210000004027 cell Anatomy 0.000 claims 30
- 108020004707 nucleic acids Proteins 0.000 claims 28
- 102000039446 nucleic acids Human genes 0.000 claims 28
- 150000007523 nucleic acids Chemical class 0.000 claims 28
- 238000000034 method Methods 0.000 claims 20
- 208000036142 Viral infection Diseases 0.000 claims 12
- 230000001413 cellular effect Effects 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 12
- 230000009385 viral infection Effects 0.000 claims 12
- 239000003550 marker Substances 0.000 claims 10
- 230000003211 malignant effect Effects 0.000 claims 8
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 241000700605 Viruses Species 0.000 claims 5
- 230000002401 inhibitory effect Effects 0.000 claims 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 108020005544 Antisense RNA Proteins 0.000 claims 4
- 238000004113 cell culture Methods 0.000 claims 4
- 239000003184 complementary RNA Substances 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 238000012216 screening Methods 0.000 claims 4
- 230000004083 survival effect Effects 0.000 claims 4
- 108700008625 Reporter Genes Proteins 0.000 claims 3
- 230000014509 gene expression Effects 0.000 claims 3
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 3
- 230000029812 viral genome replication Effects 0.000 claims 3
- 229920001817 Agar Polymers 0.000 claims 2
- 239000008272 agar Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000008030 elimination Effects 0.000 claims 2
- 238000003379 elimination reaction Methods 0.000 claims 2
- 230000002018 overexpression Effects 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 102000016897 CCCTC-Binding Factor Human genes 0.000 claims 1
- 108010014064 CCCTC-Binding Factor Proteins 0.000 claims 1
- 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 claims 1
- 102100025947 Insulin-like growth factor II Human genes 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000008034 disappearance Effects 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000036210 malignancy Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37713602P | 2002-05-02 | 2002-05-02 | |
| PCT/US2003/013743 WO2004010925A2 (en) | 2002-05-02 | 2003-05-02 | Mammalian genes involved in viral infection and tumor suppression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009240934A Division JP2010011871A (ja) | 2002-05-02 | 2009-10-19 | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006507807A JP2006507807A (ja) | 2006-03-09 |
| JP2006507807A5 true JP2006507807A5 (enExample) | 2006-09-14 |
Family
ID=31188308
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004524480A Pending JP2006507807A (ja) | 2002-05-02 | 2003-05-02 | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 |
| JP2009240934A Pending JP2010011871A (ja) | 2002-05-02 | 2009-10-19 | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009240934A Pending JP2010011871A (ja) | 2002-05-02 | 2009-10-19 | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7691599B2 (enExample) |
| EP (2) | EP1572084A4 (enExample) |
| JP (2) | JP2006507807A (enExample) |
| AU (2) | AU2003234445B2 (enExample) |
| CA (1) | CA2485092A1 (enExample) |
| WO (1) | WO2004010925A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070287684A1 (en) | 2006-05-22 | 2007-12-13 | Irshad Chaudry | Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof |
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| WO2009079452A2 (en) * | 2007-12-14 | 2009-06-25 | The Brigham And Women's Hospital, Inc. | Treatment and prevention of hiv infection |
| US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| US20110038852A1 (en) * | 2009-06-10 | 2011-02-17 | 3-V Biosciences, Inc. | Antivirals that target transporters, carriers, and ion channels |
| US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
| US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
| US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
| US9340584B2 (en) | 2011-03-29 | 2016-05-17 | The General Hospital Corporation | Engineered thioredoxin-like fold proteins |
| WO2013172969A1 (en) | 2012-05-15 | 2013-11-21 | The Uab Research Foundation | Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof |
| US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
| EP2971030B8 (en) * | 2013-03-14 | 2018-12-05 | Glycobia, Inc | Oligosaccharide compositions, glycoproteins and methods to produce the same in prokaryotes |
| WO2016090362A1 (en) * | 2014-12-05 | 2016-06-09 | Vanderbilt University | Identification of cellular antimicrobial drug targets through interactome analysis |
| EP3262174A4 (en) * | 2015-02-23 | 2018-10-17 | Ionis Pharmaceuticals, Inc. | Compounds and methods for increasing antisense activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| WO2018085208A1 (en) | 2016-11-02 | 2018-05-11 | The Research Foundation For The State University Of New York | Methods of inhibiting viruses using compositions targeting tsg101-ubiquitin interaction |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| JPH07507201A (ja) | 1992-03-10 | 1995-08-10 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ，アズ レプリゼンテッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 可変鋳型反応 |
| AU742243B2 (en) * | 1996-04-15 | 2001-12-20 | Vanderbilt University | Mammalian genes involved in viral infection and tumor suppression |
| JP2001520012A (ja) * | 1997-10-10 | 2001-10-30 | バンダービルト ユニバーシティ | ウイルス感染および腫瘍抑制に関与する哺乳動物遺伝子 |
-
2003
- 2003-05-02 EP EP03728671A patent/EP1572084A4/en not_active Ceased
- 2003-05-02 AU AU2003234445A patent/AU2003234445B2/en not_active Ceased
- 2003-05-02 WO PCT/US2003/013743 patent/WO2004010925A2/en not_active Ceased
- 2003-05-02 JP JP2004524480A patent/JP2006507807A/ja active Pending
- 2003-05-02 EP EP10188281A patent/EP2327722A3/en not_active Withdrawn
- 2003-05-02 CA CA002485092A patent/CA2485092A1/en not_active Abandoned
- 2003-05-02 US US10/513,426 patent/US7691599B2/en not_active Expired - Fee Related
-
2009
- 2009-10-19 JP JP2009240934A patent/JP2010011871A/ja active Pending
-
2010
- 2010-02-26 AU AU2010200729A patent/AU2010200729A1/en not_active Withdrawn
- 2010-03-05 US US12/718,619 patent/US20100286251A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006507807A5 (enExample) | ||
| KR102306797B1 (ko) | Pd-l1 발현의 감소를 위한 올리고뉴클레오티드 | |
| WO2006058489A1 (en) | A recombinant adeno-associated virus expressing human antisense gene cyp2j2 and its preparation methods | |
| JPWO2020163365A5 (enExample) | ||
| Tarantul et al. | Differential gene expression in B-cell non-Hodgkin's lymphoma of SIV-infected monkey | |
| WO2008024919A2 (en) | Interferon antagonists, antibodies thereto, and associated methods of use | |
| CN117363594A (zh) | 一种可控制的RNA m6A去甲基化编辑系统及其应用 | |
| JP2020510065A5 (enExample) | ||
| Chan et al. | Common carp metallothionein-1 gene: cDNA cloning, gene structure and expression studies | |
| JP6919891B2 (ja) | Ｅｐｓｔｅｉｎ−Ｂａｒｒウイルス関連癌に特異的な抗腫瘍剤 | |
| EP2871240B1 (en) | Recombinant adenovirus for simultaneously expressing pig interferon alpha and pig interferon gamma | |
| WO2025067214A1 (zh) | 一种rna甲基化的编辑系统及其应用 | |
| KR102026067B1 (ko) | 목적 유전자 발현 조절을 위한 대장균 및 코리네박테리움 글루타미쿰 셔틀 벡터 | |
| KR102680316B1 (ko) | 안티센스 올리고뉴클레오타이드 | |
| CA2305312A1 (en) | Mammalian genes involved in viral infection and tumor suppression | |
| JP2001520012A5 (enExample) | ||
| KR100701672B1 (ko) | 한국형 돌돔 이리도바이러스의 유전자 및 이를 이용한 백신 | |
| CN117203339A (zh) | 抗病毒核酸 | |
| KR102808052B1 (ko) | 불멸화된 마모셋 세포주 및 이의 제조방법 | |
| JP2006501829A (ja) | Ｈｏｘで誘導される増殖を制限する遺伝子をブロックする幹細胞増殖因子およびその方法 | |
| RU2835926C1 (ru) | Олигонуклеотиды для понижения экспрессии pd-l1 | |
| HK40077444A (en) | Oligonucleotides for reduction of pd-l1 expression | |
| HK40064608A (en) | Oligonucleotides for reduction of pd-l1 expression | |
| HK40077445A (en) | Oligonucleotides for reduction of pd-l1 expression | |
| HK40077445B (zh) | 用於减少pd-l1表达的寡核苷酸 |